Award
Delivery Order #SPE2DR26FJM5X
Delivery Order for Ondansetron Vials Under Long-Term Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$110.77
Ceiling
$110.77
Awarded
February 15, 2026
Period of Performance
Feb 15, 2026 – Feb 17, 2026
Identifier
SPE2DR26FJM5X
NAICS
424210
This award is a delivery order contract issued to AmerisourceBergen Drug Corp, a prominent pharmaceutical distribution company known for supplying medicines and healthcare products. The contract specifically procures Ondansetron HCL 4 MG/2 ML vials, which are critical antiemetic medications used to prevent nausea and vomiting in medical treatments. This delivery order falls under a larger indefinite delivery vehicle (IDV) agreement that AmerisourceBergen holds, aimed at ensuring a consistent and reliable supply of essential pharmaceuticals for government healthcare operations. The work scope involves the timely delivery of specified pharmaceutical products to support healthcare providers, contributing to effective patient care. The contract was competitively bid as part of the overarching IDV agreement, which strategically secures long-term pharmaceutical supply. The performance period for this delivery order is a short, specific timeframe within the broader multi-year IDV arrangement, indicating a focused and timely procurement action.
Description
4570841676!ONDANSETRON HCL 4 MG/2 ML VIAL 2ML